Pharmacokinetic Evaluation of Moxifloxacin IV to Enteral Switch Therapy in Intensive Care Patients

NCT00458900 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

4

Enrollment

OTHER

Sponsor class

Conditions

Pneumonia

Interventions

DRUG: IV and enteral administration of moxifloxacin

Sponsor

University Hospital, Ghent